|
FNV
FRANCO NEVADA Corp
FNV · Q3 FY2024
|
Q3 FY2024 |
|
FNV Q3 FY2024 transcript
|
|
ALB
Albemarle Corp
ALB · Q3 FY2024
|
Q3 FY2024 |
|
ALB Q3 FY2024 transcript
|
|
FTHM
Fathom Holdings Inc.
FTHM · Q3 FY2024
|
Q3 FY2024 |
|
FTHM Q3 FY2024 transcript
|
|
ESTA
Establishment Labs Holdings Inc.
ESTA · Q3 FY2024
|
Q3 FY2024 |
|
ESTA Q3 FY2024 transcript
|
|
OSCR
Oscar Health, Inc.
OSCR · Q3 FY2024
|
Q3 FY2024 |
|
OSCR Q3 FY2024 transcript
|
|
LITE
Lumentum Holdings Inc.
LITE · Q1 FY2025
|
Q1 FY2025 |
|
LITE Q1 FY2025 transcript
|
|
SGHT
Sight Sciences, Inc.
SGHT · Q3 FY2024
|
Q3 FY2024 |
|
SGHT Q3 FY2024 transcript
|
|
TPR
Tapestry, Inc.
TPR · Q1 FY2025
|
Q1 FY2025 |
|
TPR Q1 FY2025 transcript
|
|
IMVT
Immunovant, Inc.
IMVT · Q2 FY2025
|
Q2 FY2025 |
|
IMVT Q2 FY2025 transcript
|
|
FROG
JFrog Ltd
FROG · Q3 FY2024
|
Q3 FY2024 |
|
FROG Q3 FY2024 transcript
|
|
TBLA
Taboola.com Ltd.
TBLA · Q3 FY2024
|
Q3 FY2024 |
|
TBLA Q3 FY2024 transcript
|
|
PODD
Insulet Corp
PODD · Q3 FY2024
|
Q3 FY2024 |
|
PODD Q3 FY2024 transcript
|
|
IOVA
Iovance Biotherapeutics, Inc.
IOVA · Q3 FY2024
|
Q3 FY2024 |
|
IOVA Q3 FY2024 transcript
|
|
BL
Blackline, Inc.
BL · Q3 FY2024
|
Q3 FY2024 |
|
BL Q3 FY2024 transcript
|
|
PCT
PureCycle Technologies, Inc.
PCT · Q3 FY2024
|
Q3 FY2024 |
|
PCT Q3 FY2024 transcript
|
|
CLDT
Chatham Lodging Trust
CLDT · Q3 FY2024
|
Q3 FY2024 |
|
CLDT Q3 FY2024 transcript
|
|
GSAT
Globalstar, Inc.
GSAT · Q3 FY2024
|
Q3 FY2024 |
|
GSAT Q3 FY2024 transcript
|
|
DCO
Ducommun Inc /De/
DCO · Q3 FY2024
|
Q3 FY2024 |
|
DCO Q3 FY2024 transcript
|
|
DFTX
Definium Therapeutics, Inc.
DFTX · Q3 FY2024
|
Q3 FY2024 |
|
DFTX Q3 FY2024 transcript
|
|
LTRN
Lantern Pharma Inc.
LTRN · Q3 FY2024
|
Q3 FY2024 |
|
LTRN Q3 FY2024 transcript
|
|
CCOI
Cogent Communications Holdings, Inc.
CCOI · Q3 FY2024
|
Q3 FY2024 |
|
CCOI Q3 FY2024 transcript
|
|
PBH
Prestige Consumer Healthcare Inc.
PBH · Q2 FY2025
|
Q2 FY2025 |
|
PBH Q2 FY2025 transcript
|
|
WBD
Warner Bros. Discovery, Inc.
WBD · Q3 FY2024
|
Q3 FY2024 |
|
WBD Q3 FY2024 transcript
|
|
FOSL
Fossil Group, Inc.
FOSL · Q3 FY2024
|
Q3 FY2024 |
|
FOSL Q3 FY2024 transcript
|